Trial Profile
The Efficacy of Adductor-Canal-Blockade on Pain and Morphine Consumption After Revision Knee Arthroplasty.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2013
Price :
$35
*
At a glance
- Drugs Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 14 May 2013 Status changed from recruiting to completed, as reported by European Clinical Trials database
- 17 Dec 2012 Planned End Date changed from 1 Feb 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.
- 20 Sep 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.